Solid forms of N- [2,4-bis(1,1-dimethylethyl)-5-hydroxyph enyl]-1,4-dihydro-4-oxoquinoline-3-carb oxamide

Details for Australian Patent Application No. 2008301907 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Zhang, Yuegang; Demattei, John; Mudunuri, Praveen; Harrison, Cristian; Looker, Adam; Roeper, Stefanie; Feng, Yushi

Agent Spruson & Ferguson

Pub. Number AU-A-2008301907

PCT Pub. Number WO2009/038683

Priority 60/972,605 14.09.07 US

Filing date 15 September 2008

Wipo publication date 26 March 2009

International Classifications

A61K 31/47 (2006.01) - Quinolines

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 35/00 (2006.01) Antineoplastic agents

C07D 215/233 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/038683 Priority application(s): WO2009/038683

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008301913-Compositions and methods for diagnosis and treatment of type 2 diabetes

2008301905-Thiazolidinedione analogues for the treatment of hypertension